Boston Scientific Corp - Asset Resilience Ratio
Boston Scientific Corp (BSX) has an Asset Resilience Ratio of 2.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Boston Scientific Corp (BSX) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Boston Scientific Corp's Asset Resilience Ratio has changed over time. See Boston Scientific Corp book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Boston Scientific Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BSX company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.27 Billion | 2.99% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.27 Billion | 2.99% |
Asset Resilience Insights
- Limited Liquidity: Boston Scientific Corp maintains only 2.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Boston Scientific Corp Industry Peers by Asset Resilience Ratio
Compare Boston Scientific Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 5.46% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.66% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
Annual Asset Resilience Ratio for Boston Scientific Corp (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Boston Scientific Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.05% | $414.00 Million | $39.40 Billion | -1.41pp |
| 2023-12-31 | 2.46% | $865.00 Million | $35.14 Billion | -0.40pp |
| 2022-12-31 | 2.86% | $928.00 Million | $32.47 Billion | -3.11pp |
| 2021-12-31 | 5.97% | $1.93 Billion | $32.23 Billion | +0.34pp |
| 2020-12-31 | 5.63% | $1.73 Billion | $30.78 Billion | +4.92pp |
| 2019-12-31 | 0.71% | $217.00 Million | $30.57 Billion | +0.01pp |
| 2018-12-31 | 0.70% | $146.00 Million | $21.00 Billion | -4.51pp |
| 2017-12-31 | 5.20% | $991.00 Million | $19.04 Billion | +2.78pp |
| 2016-12-31 | 2.43% | $439.00 Million | $18.10 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $18.13 Billion | -- |
| 2014-12-31 | 0.02% | $3.00 Million | $16.83 Billion | +0.01pp |
| 2013-12-31 | 0.01% | $1.00 Million | $16.73 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.15 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $21.29 Billion | -- |
| 2010-12-31 | 0.00% | $0.00 | $22.13 Billion | -- |
| 2009-12-31 | 0.00% | $0.00 | $25.18 Billion | -- |
| 2008-12-31 | 0.42% | $113.00 Million | $27.08 Billion | -0.60pp |
| 2007-12-31 | 1.02% | $317.00 Million | $31.20 Billion | -0.90pp |
| 2006-12-31 | 1.92% | $596.00 Million | $31.10 Billion | -0.02pp |
| 2005-12-31 | 1.94% | $159.00 Million | $8.20 Billion | -2.27pp |
| 2004-12-31 | 4.21% | $344.00 Million | $8.17 Billion | +2.79pp |
| 2003-12-31 | 1.42% | $81.00 Million | $5.70 Billion | +1.30pp |
| 2001-12-31 | 0.13% | $5.00 Million | $3.97 Billion | -0.05pp |
| 2000-12-31 | 0.18% | $6.00 Million | $3.43 Billion | -0.22pp |
| 1999-12-31 | 0.39% | $14.00 Million | $3.57 Billion | -- |
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, dire… Read more